Volume | 29 873 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 0,88 | Bas Haut |
|||||
Minimum Bas | 0,83 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Quince Therapeutics Inc | QNCX | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
0,83 | 0,83 | 0,88 | 0,83 | 0,8323 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
216 | 29 873 | US$ 0,8510725 | US$ 25 424 | - | 0,83 - 1,70 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:02:58 | 56 | US$ 0,83 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
35,58M | 42,87M | - | 0 | -31,39M | -0,73 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Quince Therapeutics
Date | Heure | Source | Titre |
---|---|---|---|
13/5/2024 | 13:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
13/5/2024 | 13:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
06/5/2024 | 22:05 | Business Wire | Quince Therapeutics to Present at The Citizens JMP Life.. |
01/4/2024 | 13:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
22/2/2024 | 13:00 | Business Wire | Quince Therapeutics Launches Scientific Advisory Board |
15/2/2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 13:00 | Business Wire | Quince Therapeutics Appoints Former Reata Pharmaceuticals.. |
07/2/2024 | 22:05 | Business Wire | Quince Therapeutics to Present at Oppenheimer 34th Annual.. |
02/2/2024 | 23:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
04/1/2024 | 22:05 | Business Wire | Quince Therapeutics to Participate at Investor Events in.. |
03/1/2024 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Quince Therapeutics
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Quince Therapeutics Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,86 | 0,88 | 0,83 | 0,8434876 | 50 010 | -0,03 | -3,49% |
1 mois | 0,92 | 1,01 | 0,83 | 0,8994033 | 118 635 | -0,09 | -9,78% |
3 mois | 1,19 | 1,2543 | 0,83 | 0,9844556 | 88 874 | -0,36 | -30,25% |
6 mois | 0,966 | 1,4301 | 0,83 | 1,09 | 88 935 | -0,136 | -14,08% |
1 an | 1,53 | 1,70 | 0,83 | 1,18 | 139 054 | -0,70 | -45,75% |
3 ans | 41,64 | 121,98 | 0,5401 | 10,67 | 615 741 | -40,81 | -98,01% |
5 ans | 26,75 | 121,98 | 0,5401 | 15,15 | 429 969 | -25,92 | -96,90% |